Electromed Profit Margin 2010-2019 | ELMD
Current and historical gross margin, operating margin and net profit margin for Electromed (ELMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Electromed net profit margin as of December 31, 2019 is 11.07%.
|Electromed Annual Profit Margins
|Electromed Quarterly Profit Margins
||Medical Instruments Manufacturing
Electromed, Inc. manufactures, markets and sells products that provide airway clearance therapy to patients with compromised pulmonary function. The Company is the designer, manufacturer and worldwide provider of the SmartVest? Airway Clearance System and related products. The patented system uses High Frequency Chest Wall Oscillation (HFCWO), an alternative to Chest Physiotherapy (CPT), to deliver airway clearance treatment. The Company manufactures its products for use by chronically-ill patients who face health risks due to pneumonia and mucus accumulation in the lungs, particularly patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), bronchiectasis, and neuro-muscular disorders. The purpose of its primary product, the SmartVest System, is to loosen, mobilize, and release respiratory secretions from the lungs. The Company's products are primarily used in the home health care market and in hospitals. Electromed, Inc. is headquartered in New Prague, Minnesota.